Anil Raghavan - Chief Executive Officer
Mr. Anil Raghavan is the Chief Executive Officer of SPARC since April, 2014. In his role as CEO, Mr Raghavan sets SPARC’s strategic priorities and focuses on developing the portfolio prudently and driving long-term stockholder value.
Mr. Raghavan is a senior Pharmaceutical Services executive with significant global exposure spanning business strategy and operations. Prior to joining SPARC in 2014, he served as the Managing Director of India and Sri Lanka business of Quintiles and has been an active member of their Asia Management Board. Under his watch, Quintiles India maintained strong double-digit revenue and operating surplus growth in a turbulent business environment. He spent the first half of his career in the Consulting Industry with leading firms such as Arthur Andersen, KPMG and Cambridge Technology Partners. He helped the leadership teams of several companies in developing/evaluating strategies and improving business performance. He has led/participated in several industry sector studies, working with business lobbies and industry associations to highlight sectoral opportunities and challenges. Mr. Raghavan is an Industrial Engineer with a deep interest in evolving science and technologies enabling pharmaceutical R&D and health care. His other interests include the New Media, Digital Photography and Carnatic Music.
Nitin Dharmadhikari - Executive Vice-President Formulation Development
Dr. Nitin Dharmadhikari Executive Vice-President – R&D (Formulation Development) oversees the development of innovative formulation's based on SPARC’s proprietary Novel Drug Delivery Platforms.
Dr. Dharmadhikari has more than 25 years of Industry experience. After working with companies like Dr. Reddy’s & Ranbaxy, he joined Sun Pharma in 1999 and looked after generic product development for US and Europe.He moved to SPARC in March 2007. He is a co-inventor of two innovative platform technologies i.e., Wrap Matrix™ and GRID™ technologies. He is inventor or co-inventor of more than 50 patent / patent applications.
Siu-Long Yao - Sr. Vice–President Clinical Development & Operations
Siu-Long Yao, Sr. Vice-President for Clinical Development & Operations, oversees design & execution of clinical research globally.
Siu brings in 20 years of experience in clinical research. Prior to joining SPARC, he held positions of increasing responsibility in Clinical Pharmacology & Oncology at Merck, Sanofi-Aventis and Schering-Plough. He completed sub-specialty training in hematology & oncology at Johns Hopkins and is a Board certified Internist, Hematologist and Oncologist.
Nitin Damle - Sr. Vice-President and Chief Innovation Officer
Nitin Damle, Sr. Vice–President and Chief Innovation Officer, oversees collaboration with external partners and leads the development of Biologics at SPARC.
Nitin brings in 30 years of experience in drug discovery and preclinical development in Oncology and Immuno-Inflammatory therapeutic areas with focus on both small molecules and biologics. He was Director of Oncology and Immuno-Inflammatory diseases at Wyeth, and Sr. Director of Preclinical Research at Endo Pharmaceuticals before joining SPARC.
Trinadha Rao Chitturi - Sr. Vice–President Medicinal Chemistry
Dr. Trinadha Rao Chitturi, Sr. Vice–President & Head, Medicinal Chemistry, oversees design and synthesis of NCE’s for therapeutic targets of interest with regard to the new drug discovery programs.
Dr Rao carries over 22 years of experience in synthetic organic/ medicinal chemistry together at SPIL & SPARC Ltd. Prior to joining SUN, Dr Rao was associated with GlaxoSmithkline Pharmaceuticals Ltd. Thane, as Group Leader in Chemistry R&D. for about 4 years.
Vikram Ramanathan - Vice-President and Head of Translational Development
Vikram Ramanathan, Vice-President and Head of Translational Development at SPARC, is responsible for Preclinical Pharmacology, Drug Metabolism & Pharmacokinetics and Bioanalysis, and Regulatory Toxicology. Vikram has 20+ years’ experience in Pharma Drug Discovery and Development having worked both in the US and in India.
Vikram received his PhD in Pharmaceutical Chemistry (Pharmaceutics Pathway) at the University of California San Francisco where he studied the role of mammalian epithelial neurotransmitter transporters in pharmacokinetics and disposition in the laboratory of Dr Kathleen M. Giacomini. He then did a post-doctoral fellowship in molecular neurobiology at the NIH, Bethesda in the laboratory of Dr Zach W. Hall, studying the oligomerization of the muscarinic acetylcholine receptor.
Vikram started his pharma career at SmithKline Beecham Pharmaceuticals in the Philadelphia area spending several years in its DMPK department before returning to India in 2003. He joined Advinus Therapeutics Ltd. with its founding team to set up its DMPK and Bioanalysis department in Bangalore and was also responsible for clinical candidate optimization. He then worked at Cadila Healthcare Ltd. as Vice President and Head, supporting DMPK and Bioanalysis for NCEs, generics and biologicals. In his most recent stint Vikram was Sr. Vice President & COO of Advinus Therapeutics with responsibility for the scientific functions including Chemistry, Analytical R&D, Pharmacology, DMPK & Bioanalysis and Safety Assessment.
Chetan Rajpara - Chief Financial Officer
Chetan Rajpara, CFO, joined SPARC in February 2017 and is responsible for Finance, Accounts, Taxation and Legal & Secretarial functions.
Prior to joining SPARC, Chetan was associated with Sun Pharma since 1993 and has spent over 24 years with Sun Pharma in various leadership positions and has worked across multiple areas like Accounts, Distribution, International Logistics and Finance & Treasury.
Chetan was instrumental in setting up Treasury for Sun Pharma in 2003. He was designated Vice-President in April 2016 and was responsible for FX & Interest Rate Risk Management, Cash & Liquidity Management, Fund Raising, Investments, Banking Relationships, International Trade Transactions, RBI Compliance and Global Insurance Programme.
Chetan worked with The Dharamsi Morarji Chemical Company Limited as Chief Accountant from 1990 to 1993. He is a Graduate Member of ICWAI, Calcutta (1989) and a Commerce Graduate with distinction from H.L. College of Commerce, Ahmedabad (1986). Chetan completed his Post Graduate Executive Management Programme from SP Jain Institute of Management & Research, Mumbai in 2014.
Shravanti Bhowmik - Vice–President Program Management
Dr. Shravanti Bhowmik, Vice–President & Head, Program Management, oversees all aspects of the development/implementation of projects and programs involving cross-functional teams, coordinating between line management, internal, and external resources, planning and directing schedules as well as project budgets.
Shravanti carries over 17 years of experience in academics, medical affairs, medico-marketing, pharmacovigilance, clinical operations, and clinical development. She is a clinical pharmacologist, post graduate in executive management from S.P. Jain Institute of Management & Research, Mumbai, and a Project Management Professional, Certified through Project Management Institute.
Michael Choi - Vice-President Business Development
Michael Choi, Vice-President and Head of Business Development at SPARC, is responsible for global business development, commercial strategy and investor relations.
Michael holds an MBA in Finance and Economics from Columbia Business School and a BA in History with a Pre-Medical Sciences concentration from Columbia College in New York. Michael has over 20 years of experience in strategy, business development and investments in the biopharmaceutical industry and has successfully completed corporate transactions in six continents. His areas of expertise include search and evaluation of biopharmaceutical assets, product and pipeline valuations, and structuring partnership deals in an international setting.
Prior to joining SPARC, Michael was the Business Alliance Lead for Greater China, Asia-Pacific, Latin America and Canada for Pfizer Essential Health. He also held roles at Life Technologies (now Thermo Fisher Scientific), FrankelGroup (now Huron Consulting), Envision Consulting Group (now IQVIA) and PricewaterhouseCoopers. Michael started his career in clinical research at the Columbia Presbyterian Medical Center Department of Cardiothoracic and Vascular Surgery
Anuja Ratan - HR Business Partner
Anuja oversees the Human Resources and Admin function at SPARC. Anuja brings with her rich experience of over 15 years in the field of Human Resources in fast growing organisations. Prior to joining SPARC, she has been associated with Boston Analytics, Tata Communications and Royal Bank of Scotland. Anuja is a post-graduate in Management with specialisation in Human Resources.